Kuulitko uudesta Alzheimer-lääkkeestä?

Toimii vähentämällä beta amylodia aivoissa.

There were some adverse events in the trial, the companies said, including about 20% of Lecanemab-treated patients who experienced brain swelling or brain bleeding, although side effects were largely asymptomatic.

https://abcnews.go.com/Health/new-data-shows-alzheimers-drug-slow-cogni…

Siitäpä tulikin mieleeni toinenkin aine, joka toimii samoin mutta ei turvota aivoja:

https://www.salk.edu/news-release/cannabinoids-remove-plaque-forming-al…

https://www.salk.edu/news-release/active-ingredient-in-cannabis-protect…

Ja toisaalta esim. alkoholilla ei potentiaalisia hyötyjä ole havaittu.